ResearcherXiamen UniversityActive in the last 2 years
Pengfei Guo
Matched on ORCID iD 0009-0009-1989-2508; OpenAlex author ID A5100638841. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 12
2020: 2 papers · 2021: none · 2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 1 paper
Papers 5
- Metabolic, transcriptomic, and proteomic adaptations in pancreatic ductal adenocarcinoma-patient derived xenograft models across serial passages. Co-author DOI 10.1186/s12967-025-06787-7↗
- Metabolic responses to the occurrence and chemotherapy of pancreatic cancer: biomarker identification and prognosis prediction. Co-author DOI 10.1038/s41598-024-56737-4↗
- Metabolomic analyses redefine the biological classification of pancreatic cancer and correlate with clinical outcomes. Co-author DOI 10.1002/ijc.34208↗
- Understanding metabolomic characteristics of pancreatic ductal adenocarcinoma by HR-MAS NMR detection of pancreatic tissues. Co-author DOI 10.1016/j.jpba.2020.113546↗
- Chemotherapeutic efficacy of cucurmosin for pancreatic cancer as an alternative of gemcitabine: a comparative metabolomic study. Co-author DOI 10.21037/gs-20-202↗
Closest collaborators
The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jianghua Feng · 5 shared papers, 2020–2025 · strength 0.88
- Paper Metabolic, transcriptomic, and proteomic adaptations in pancreatic ductal adenocarcinoma-patient derived xenograft mode… DOI 10.1186/s12967-025-06787-7↗
- Paper Metabolic responses to the occurrence and chemotherapy of pancreatic cancer: biomarker identification and prognosis pre… DOI 10.1038/s41598-024-56737-4↗
- Paper Metabolomic analyses redefine the biological classification of pancreatic cancer and correlate with clinical outcomes. DOI 10.1002/ijc.34208↗
- Heguang Huang · 4 shared papers, 2020–2025 · strength 0.77
- Paper Metabolic, transcriptomic, and proteomic adaptations in pancreatic ductal adenocarcinoma-patient derived xenograft mode… DOI 10.1186/s12967-025-06787-7↗
- Paper Metabolic responses to the occurrence and chemotherapy of pancreatic cancer: biomarker identification and prognosis pre… DOI 10.1038/s41598-024-56737-4↗
- Paper Metabolomic analyses redefine the biological classification of pancreatic cancer and correlate with clinical outcomes. DOI 10.1002/ijc.34208↗
- Tianhong Teng · 4 shared papers, 2020–2025 · strength 0.74
- Paper Metabolic, transcriptomic, and proteomic adaptations in pancreatic ductal adenocarcinoma-patient derived xenograft mode… DOI 10.1186/s12967-025-06787-7↗
- Paper Metabolic responses to the occurrence and chemotherapy of pancreatic cancer: biomarker identification and prognosis pre… DOI 10.1038/s41598-024-56737-4↗
- Paper Metabolomic analyses redefine the biological classification of pancreatic cancer and correlate with clinical outcomes. DOI 10.1002/ijc.34208↗
- Wen Shi · 2 shared papers, 2020–2025 · strength 0.36
- Paper Metabolic, transcriptomic, and proteomic adaptations in pancreatic ductal adenocarcinoma-patient derived xenograft mode… DOI 10.1186/s12967-025-06787-7↗
- Paper Understanding metabolomic characteristics of pancreatic ductal adenocarcinoma by HR-MAS NMR detection of pancreatic tis… DOI 10.1016/j.jpba.2020.113546↗
- Binbin Wei · 2 shared papers, 2020–2022 · strength 0.28
- Xianchao Lin · 1 shared paper, 2025 · strength 0.23
- Jin Zhang · 1 shared paper, 2024 · strength 0.23
- Sanxi Wang · 1 shared paper, 2020 · strength 0.13
- Congfei Wang · 1 shared paper, 2020 · strength 0.11
- Heguang Huang · 1 shared paper, 2020 · strength 0.11
- Jieming Xie · 1 shared paper, 2020 · strength 0.11
- Minghuang Chen · 1 shared paper, 2020 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.